Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Ductal carcinoma in situ in BRCA mutation carriers.

Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL.

J Clin Oncol. 2007 Feb 20;25(6):642-7. Epub 2007 Jan 8.

PMID:
17210933
2.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
3.

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.

Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D.

Medicine (Baltimore). 2016 Oct;95(40):e4975. Review.

4.

Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.

Rivenbark AG, Coleman WB.

Exp Mol Pathol. 2012 Dec;93(3):391-8. doi: 10.1016/j.yexmp.2012.10.018. Epub 2012 Nov 6. Review.

PMID:
23142414
5.

The role of BRCA mutation testing in determining breast cancer therapy.

Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M, Ward RL.

Nat Rev Clin Oncol. 2010 Dec;7(12):708-17. doi: 10.1038/nrclinonc.2010.175. Epub 2010 Nov 9. Review.

PMID:
21060331
6.

[Hereditary breast and ovarian cancer].

Lax SF.

Pathologe. 2017 May;38(3):149-155. doi: 10.1007/s00292-017-0298-5. Review. German.

PMID:
28500412
7.

Epidemiology of breast cancer among BRCA mutation carriers: an overview.

Nkondjock A, Ghadirian P.

Cancer Lett. 2004 Mar 8;205(1):1-8. Review.

PMID:
15040392
8.

Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, Steel M, Streuli C.

Breast Cancer Res. 2008;10(2):R26. doi: 10.1186/bcr1983. Epub 2008 Mar 27. Review.

9.

Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society.

Vatovec C, Erten MZ, Kolodinsky J, Brown P, Wood M, James T, Sprague BL.

Crit Rev Eukaryot Gene Expr. 2014;24(4):281-6. Review.

10.

Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer: Data Points # 15.

Jarosek S, Tuttle TM, Durham S, Virnig BA.

Data Points Publication Series [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011-.
2012 Aug.

11.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Mazzola E, Blackford A, Parmigiani G, Biswas S.

Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Review.

12.

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.

Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S.

Breast Cancer Res Treat. 2017 Apr;162(2):225-230. doi: 10.1007/s10549-017-4122-y. Epub 2017 Jan 30. Review.

PMID:
28138892
13.

Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.

Segnan N, Minozzi S, Armaroli P, Cinquini M, Bellisario C, González-Lorenzo M, Gianola S, Ponti A.

Int J Cancer. 2016 Aug 1;139(3):554-73. doi: 10.1002/ijc.30105. Epub 2016 Apr 15. Review.

14.

The Consequences of a BRCA Mutation in Women.

Famorca-Tran J, Roux G.

J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1. Review. No abstract available.

Supplemental Content

Support Center